WHAT: "Individualizing the Treatment of Psychoses" Learn how atypical antipsychotics have revolutionized patient quality of life.
WHEN: May 31, 1998 9:00 am to 12:00 pm EST
WHERE: The American Psychiatric Association Annual Meeting
Royal York Hotel, Canadian Room
100 Front Street
WestToronto, Canada M5J1E3
416/368-2511
WHO: Introduction, S. Charles Schultz, M.D., Chairperson "Impact of Phases and Severity of Illness on Treatment Decisions Across the Age Spectrum," Robert L. Findling, M.D. "Management of Psychotic Aspects of Schizoaffective Disorder," Stephen M. Strakowski, M.D. "Treating Symptoms Comorbid with Psychosis in Schizophrenia," Jeffrey A. Lieberman, M.D. "Treatment Issues with the Use of Antipsychotic Medications," Sharon G. Dott, M.D. "After Responding: What Happens Next?" Peter J. Weiden, M.D. Questions and Answers, S. Charles Schulz
WHAT: "New Atypicals: Data Versus Clinical Experience"
WHEN: May 31, 19981:30 pm to 4:30 pm EST
WHERE: The American Psychiatric Association Annual Meeting
Royal York Hotel, Canadian Room
100 Front Street
West Toronto, Canada M5J1E3
416/368-2511
WHO: "Historical Overview of the Treatment of Schizophrenia," Ira D. Glick, M.D. "Therapeutic Implications of Etiological Research," Robin M. Murray, M.D. "Atypical Antipsychotics: How Well Do They Really Work?" Rajiv Tandon, M.D. "Newer Antipsychotics: Side Effect Profiles," Stephen R. Marder, M.D. "Services Research and the Use of Atypical Antipsychotics," Lisa B. Dixon, M.D. "Combining Atypicals With Psychosocial Interventions," Ira D. Glick, M.D. Panel Discussion/Questions and Answers, Stephen R. Marder, Moderator
-- These symposia are sponsored by the American Psychiatric Association and supported by an unrestricted grant from Zeneca Pharmaceuticals, manufacturer of SEROQUEL(r) (quetiapine fumarate) tablets, an atypical antipsychotic indicated for the management of the manifestations of psychotic disorders, including schizophrenia.
-- Please see below for background information on symposium presenters.
-- For more information or to schedule an interview, contact Rob Couter at 312/329-7514 or [email protected] or Rachel Bloom at 302/886-7858 or [email protected]
Symposium Presenters
S. Charles Schultz, M.D.
Sellmann Charles Schultz, II, M.D., serves as professor and chair of the department of psychiatry at Case Western Reserve University in Cleveland, Ohio. He also is a faculty member at the Center for Adolescent Health at Case Western. Dr. Schultz participates on the editorial boards of Schizophrenia Bulletin, Advances in Neuropsychiatry and Psychopharmacology, Psychopharmacology Bulletin and Schizophrenia Research.
Robert L. Findling, M.D.
Robert L. Findling, M.D., is an assistant professor of psychiatry, pediatrics and adolescent health at Case Western Reserve University in Cleveland, Ohio. His numerous clinical appointments include serving as founding director of Child and Adolescent Psychopharmacology Research and Service at the University Hospitals of Cleveland as well as founding medical director of Pediatric Assessment and Evaluation Service in the Division of Child and Adolescent Psychiatry at University Psychiatric Center in Cleveland.
Stephen M. Strakowski, M.D.
Stephen M. Strakowski, M.D., is an associate professor of psychiatry, psychology and neuroscience at the University of Cincinnati College of Medicine. He also serves as research affiliate in psychiatry for the Psychotic Disorders Program in Belmont, MA, and as attending psychiatrist for the University of Cincinnati Hospital. Additionally, Dr. Strakowski serves on the editorial boards of several publications, including Psychiatric Research, the International Journal of Psychiatry in Medicine, and Schizophrenia Research.
Jeffrey A. Lieberman, M.D.
Jeffrey A. Lieberman, M.D., serves as professor of psychiatry, pharmacology and radiology and vice-chairman for research in the Department of Psychiatry at the University of North Carolina School of Medicine. He also serves as adjunct professor of psychiatry and radiology at Duke University School of Medicine and director of the Mental Health and Neuroscience Clinical Research Center at the University of North Carolina School of Medicine. Dr. Lieberman's research has focused on the neurobiology and pharmacology of schizophrenia and related psychotic disorders.
Sharon G. Dott, M.D.
Sharon Gail Dott, M.D., is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical Branch in Galveston. She also serves as medical director at the Crisis Resolution Unit and Intensive Treatment Programs of the Gulf Coast Center in Texas. Dr. Dott's areas of expertise include quality of life research for the mentally ill, and safety and efficacy of schizophrenia treatments.
Peter J. Weiden, M.D.
Peter J. Weiden, M.D., is director of the Neurobiological Disorders Service of St. Luke's-Roosevelt Hospital Center and an associate professor of clinical psychiatry at Columbia University. He also is a fellow in psychiatric epidemiology at the School of Public Health at Columbia University. He has served as clinical investigator for several of the newer antipsychotic medications, and currently is beginning to research the impact these agents may have on medication compliance and relapse under "real world" conditions.
Ira D. Glick, M.D.
Ira D. Glick, M.D., serves as professor of psychiatry and director of inpatient services at Stanford University School of Medicine. His primary professional activities involve research and teaching in psychiatry with emphasis on mood disorders and schizophrenia and their treatment outcome, family therapy, and psychopharmacology. In 1997, Dr. Glick was honored with the Association for Academic Psychiatry Annual Education Award for outstanding contributions as an educator, both in curriculum and development and in presentation.
Robin M. Murray, M.D.
Robin M. Murray, M.D., is a professor of psychological medicine and head of the Joint Department of Psychological Medicine of King's College School of Medicine in London and the Institute of Psychiatry. With a staff of more than 100, this currently is the largest group of schizophrenia researchers at any center outside the U.S. Dr. Murray also serves as honorary consultant for Maudsley and Bethlem Royal Hospitals.
Rajiv Tandon, M.D.
Rajiv Tandon, M.D., serves as director of the hospital services division in the Department of Psychiatry at the University of Michigan Medical Center in Ann Arbor where he also directs the schizophrenia program. He has contributed to more than 100 scientific publications, edited one book, delivered more than 24 scientific presentations and has received several awards for research in teaching schizophrenia.
Stephen R. Marder, M.D.
Stephen R. Marder, M.D., has served as a professor and vice chair of the Department of Psychiatry at the University of California,
Los Angeles since 1991. In addition, he serves as chief of the psychiatry department and director of the Mental Illness Research Education and Clinical Center (MIREC) at the West Lost Angeles Veterans Affairs Medical Center. Dr. Marder also serves as associate editor of the Schizophrenia Bulletin and advisory board member for the Journal of Neurotransmission.
Lisa B. Dixon, M.D.
Lisa Beth Dixon, M.D., M.P.H., serves as associate professor in the Department of Psychiatry at the University of Maryland School of Medicine and as staff psychiatrist for Fayette Street Clinic, University of Maryland Lead Agency. Beginning June of this year, she also will serve as director of educational development, education and training, and residency training. Dr. Dixon serves as reviewer for numerous publications including Schizophrenia Bulletin, Archives of General Psychiatry, and Schizophrenia Research.
# # #
RSS